These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 27043030

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15.
    Fertrin KY, Lanaro C, Franco-Penteado CF, de Albuquerque DM, de Mello MR, Pallis FR, Bezerra MA, Hatzlhofer BL, Olbina G, Saad ST, da Silva Araújo A, Westerman M, Costa FF.
    Am J Hematol; 2014 Apr; 89(4):385-90. PubMed ID: 24860871
    [Abstract] [Full Text] [Related]

  • 4. Association of hepcidin and anemia in early chronic kidney disease.
    Sonkar SK, Singh NK, Sonkar GK, Pandey S, Bhosale V, Kumar A, Usman K.
    Saudi J Kidney Dis Transpl; 2019 Apr; 30(2):315-324. PubMed ID: 31031367
    [Abstract] [Full Text] [Related]

  • 5. Zonulin, inflammation and iron status in patients with early stages of chronic kidney disease.
    Lukaszyk E, Lukaszyk M, Koc-Zorawska E, Bodzenta-Lukaszyk A, Malyszko J.
    Int Urol Nephrol; 2018 Jan; 50(1):121-125. PubMed ID: 29134616
    [Abstract] [Full Text] [Related]

  • 6. Growth differentiation factor 15 is related to anemia and iron metabolism in heart allograft recipients and patients with chronic heart failure.
    Przybyłowski P, Wasilewski G, Bachorzewska-Gajewska H, Golabek K, Dobrzycki S, Małyszko J.
    Transplant Proc; 2014 Oct; 46(8):2852-5. PubMed ID: 25380934
    [Abstract] [Full Text] [Related]

  • 7. Hepcidin and diabetes are independently related with soluble transferrin receptor levels in chronic dialysis patients.
    Belo L, Rocha S, Valente MJ, Coimbra S, Catarino C, Bronze-da-Rocha E, Rocha-Pereira P, do Sameiro-Faria M, Oliveira JG, Madureira J, Fernandes JC, Miranda V, Santos-Silva A.
    Ren Fail; 2019 Nov; 41(1):662-672. PubMed ID: 31296086
    [Abstract] [Full Text] [Related]

  • 8. Growth differentiation factor GDF-15 does not influence iron metabolism in stable chronic haemodialysis patients.
    Li XY, Ying J, Li JH, Zhu SL, Li J, Pai P.
    Ann Clin Biochem; 2015 May; 52(Pt 3):399-403. PubMed ID: 25178559
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Anemia of chronic diseases in the early stages of chronic kidney disease as a risk factor for cardiovascular complications in patients with glomerulonephritis].
    Markina MV, Milovanova LY, Lysenko LV, Milovanova SY, Volkov AV, Beketov VD, Lebedeva MV, Nezhdanov KS, Moiseev SV.
    Ter Arkh; 2024 Jul 07; 96(6):606-613. PubMed ID: 39106502
    [Abstract] [Full Text] [Related]

  • 11. Hepcidin and proinflammatory markers in children with chronic kidney disease: A case-control study
.
    Goyal KK, Saha A, Sahi PK, Kaur M, Dubey NK, Goyal P, Upadhayay AD.
    Clin Nephrol; 2018 May 07; 89(5):363-370. PubMed ID: 29451472
    [Abstract] [Full Text] [Related]

  • 12. The relation of hepcidin to iron disorders, inflammation and hemoglobin in chronic kidney disease.
    Mercadal L, Metzger M, Haymann JP, Thervet E, Boffa JJ, Flamant M, Vrtovsnik F, Houillier P, Froissart M, Stengel B, NephroTest Study Group.
    PLoS One; 2014 May 07; 9(6):e99781. PubMed ID: 24978810
    [Abstract] [Full Text] [Related]

  • 13. Assessment of serum bioactive hepcidin-25, soluble transferrin receptor and their ratio in predialysis patients: Correlation with the response to intravenous ferric carboxymaltose.
    Drakou A, Margeli A, Theodorakopoulou S, Agrogiannis I, Poziopoulos C, Papassotiriou I, Vlahakos DV.
    Blood Cells Mol Dis; 2016 Jul 07; 59():100-5. PubMed ID: 27282576
    [Abstract] [Full Text] [Related]

  • 14. Systemic inflammation up-regulates serum hepcidin in exacerbations and stabile chronic obstructive pulmonary disease.
    Tandara L, Grubisic TZ, Ivan G, Jurisic Z, Tandara M, Gugo K, Mladinov S, Salamunic I.
    Clin Biochem; 2015 Dec 07; 48(18):1252-7. PubMed ID: 26164540
    [Abstract] [Full Text] [Related]

  • 15. Iron Status and Inflammation in Early Stages of Chronic Kidney Disease.
    Łukaszyk E, Łukaszyk M, Koc-Żórawska E, Tobolczyk J, Bodzenta-Łukaszyk A, Małyszko J.
    Kidney Blood Press Res; 2015 Dec 07; 40(4):366-73. PubMed ID: 26160488
    [Abstract] [Full Text] [Related]

  • 16. The Content of Reticulocyte Hemoglobin and Serum Concentration of the Soluble Transferrin Receptor for Diagnostics of Anemia in Chronically Hemodialyzed Patients.
    Kurzawa T, Owczarek A, Strzelczyk JK, Gołąbek K, Wiczkowski A.
    Adv Clin Exp Med; 2016 Dec 07; 25(3):425-31. PubMed ID: 27629729
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.